The recent identification that EpCAM and AGR2 proteins are coexpressed at a very high frequency in human esophageal adenocarcinoma cancer biopsies (27) provides a clinical rationale to further dissect the AGR2-EpCAM pathway control in relation to carcinogenesis and potential therapeutics in this cancer type. Here, EPCAM is linked to cancer.